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PVC: Health Implicationsand Production Trends
by Myra Karstadt*
Poly(vinyl chloride) (PVC) is a complex plastic system. Individual components of
the PVC system, including residual vinyl chloride monomer (RVCM) and certain
additives, may pose risks of harm to human health. There have been significant reduc-
tions in the RVCM content of PVC resin since 1974, reducing the cancer risk of work-
ers in PVC fabrication plants and consumers of PVC products. A "no-effect" level for
vinyl chloride monomer (VCM)-induced carcinogenesis has not been found to date;
therefore, the significance of human exposure to low levels of RVCM remains to be
determined. Exposure to PVC dust may cause pulmonary dysfunctions. Pulmonary
and other possible health effects of PVC dust require further study. The PVC plastics
system should be characterized as to interactions among its various components and
as to interactions of the components and the PVC system as a whole with biological
systems.
In January 1974, B.F. Goodrich Chemical
Company announced that three reactor work-
ers in a poly(vinyl chloride) (PVC) polymeri-
zation plant had developed a rare cancer, angio-
sarcoma of the liver. Exposure to vinyl chlo-
ride was linked to development of angiosar-
coma of the liver by subsequent epidemiological
studies. Animal studies, several initiated be-
fore the B.F. Goodrich announcement, also
link exposure to vinyl chloride (VCM) with
development of cancer.
Regulations promulgated in the United
States of America since early 1874 have re-
sulted in the lowering of VCM concentrations
in the atmosphere of PVC manufacturing
plants, and decreased concentrations of VCM
in PVC resin. This has reduced the cancer risk
of PVC production workers, workers in PVC
fabrication plants and the ultimate consumers
of fabricated PVC products.
We are now at a crucial stage as regards
studies of the effects of plastics and plastics
components on human health. Human expo-
sure to massive doses of VCM, whether due to
uncontrolled venting of PVC polymerization
vessels or the voluntary venting in a home
bathroom of an aerosolized VCM hair spray, is
essentially over. The time has come for study
of possible health hazards posed by the com-
plex plastic system called PVC.
* 3003 Van Ness, Washington, D.C. 20008.
Why be concerned about PVC? A publica-
tion (1) states that: "Total world employment
in the VCM and PVC producing industries is
likely to be well over 70,000 workers. Those
employed in industries which use PVC as a
basic element are likely to total in the millions.
Those who come in contact with PVC every
day in some form or other probably make up
about at least one-third of the human race."
What are the human health effects of PVC?
There are several components of PVC which,
on their own, could affect human health ad-
versely: VCM, PVC dust considered as a dust,
additives of various sorts. ("Additives" for our
purposes includes stabilizers, colorants, flame
retardants, plasticizers, fillers, etc.)
But one cannot consider the components of
PVC solely as independently acting potentially
toxic agents. PVC is a complex chemical sys-
tem with little-understood interactions, both
physical and chemical, among its components.
Leaving aside the multicomponents inter-
action problem for the time being, consider
the individual components of PVC which may
pose risk of harm to humans.
VCM is already identified as a cancer-causing
agent. Even given the reductions of VCM in
PVC resin, which have been achieved by
changes in both production and compounding
procedures, some RVCM (residual vinyl chlo-
ride monomer) is still present in PVC.
October 1976 107Table 1. April 1975 status of suspension resin stripping.a
Suspension
Number of suspension resin production, RVCM,




C 5 100 <400
D 80 400
20 500-700





F 15 100 <400
G 4 (Homopolymer) 6 1500
14 2500
80 100
4 (Copolymer) 16 300
84 400







a Based on data from responses to 3/31/75 section 114 request (4).
b All suspension resins to be reduced to <400 ppm RVCM by 7/75.
e Some values are speculative until improved stripping is installed.
In 1974 Rowe (2) estimated the average
monomer concentration of PVC resin to be
approximately 1000 ppm. As shown in Table
1, RVCM concentrations of 100 ppm or less
for suspension resins before compounding were
not unusual by April 1975. An advertisement
(3) run in July 1975 by a major manufacturer
of PVC stated that general-purpose PVC homo-
polymers and blending resins were being pro-
duced with a maximum of 10 ppm, and usually
less than 5 ppm, RVCM.*
Tables 1-3, taken from a U.S. Environmental
Protection Agency (EPA) publication (4)
* The advertisement states (in part): "At Tenneco,
we've developed a unique new production technology
that allows us to produce our general purpose PVC
homopolymer, blending and dispersion resins with no
more than 10 parts per million of VCM(vinyl chloride
monomer). In fact, the typical VCM content of these
homopolymer and blending resins is less than 5 parts
per million and under 3 parts for our dispersion resins.
And, we are producing our flexible compounds at non-
detectable(less than 1 ppm) levels.
"This is a 98%o to 99% reduction from what was once
the typical practice of the industry for residual VCM."
give some idea of the present RVCM in several
PVC resins. In particular, note company E in
Table 1. 86.8%c<G of suspension resin production
is said to be at 0-50 ppm RVCM (with a foot-
noted qualification that "some values are spec-
ulative until improved stripping is installed".)
Note also that for company A, 60% of whose
resin had a RVCM concentration of 2000-4000
ppm in April 1975, with the remaining 40%
at 4000-6000 ppm, "all suspension resins
(were) to be reduced to less than 400 ppm
RVCM by 7/75."
Health problems which may be associated
with RVCM in finished PVC resin are of im-
portance to workers and consumers. The resi-
dual VCM in the old high-residue PVC evi-
dently posed problems for workers in fabrica-
tion plants. Data collected by the United States
National Institute for Occupational Safety and
Health (NIOSH) indicate that several angio-
sarcoma cases were identified in fabrication
plant workers in this country and abroad
(Table 4) (5).
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ppm (avg.) Emission
VCM VCM out VCM factor,
ASTM into stripper, of stripper out of dryer, kg VCM/
cell classa Prod, % ppm (dry basis), ppm (avg.) 100 kg PVC
GP1-26250 5 (40-60) X 103 3,050 308 0.27
GP2-16340 5 (40-60) X 103 2,050 162 0.18
GP3-15340 13 (50-70) X 103 1,200 104 0.09
GP4-15340 35 (60-90) X 103 1,050 95 0.09
GP6-15343 24 (90-120) X 103 950 82 0.08
GP1-14443 0 (80-100) X 103 600b 25 0.06
GP2-14443 1 (80-100) X 103 550 16 0.06
GP3-15433 1 (80-100) X 103 500 21 0.05
GP5-15433 5 (90-110) X 103 450 15 0.05
GP6-15433 9 (100-140) X 103 450 18 0.05
Copolymers
Cll-8500 1 (40-60) X 103 2,100 280 0.18
Cll-3500 1 (90-110) X 103 1,000 95 0.09
a ASTM celi class is standard definition of resin (ASTM-D-1755).
b Based on limited data (less than three samples) (4).
NIOSH data (Table 5) presented in late Administration (OSHA) standard (7). Again
1974 (6a) indicated that breathing zone sam- quoting Wagoner (6b): "I think it [the occur-
ples in fabrication plants turned up relatively rence of angiosarcoma of the liver in fabrica-
low concentrations of VCM-even at a time tion plant workers] points to the possibility of
when RVCM concentrations were high com- low level exposure being obviously very haz-
pared to today's values. Even at that time, as ardousep
Wagoner~pu.t 6c, ftesmlswr A recent contract study (8) prepared for Wagoner put it: "60%). of the samples were NIOSH reported on fabricating plant VCM
less than 1 ppm (6b). This level (1 ppm) is concentrations in 1975. The VCM concentra-
the maximum exposure level (8-hr time- tions are, in a number of cases, very low (less
weighted average) currently permitted by the than 0.01 ppm, the limit of detection). How-
United States Occupational Safety and Health ever, certain work stations had values which
Table 3. April 1975 status of dispersion resin stripping with protection of future capabilities.a
Current RVCM, ppm Projected RVCM Time to implement controls
Plant after stripper in product after stripper, ppm needed to meet projected levels, months
A 30,000 1-3 20,000 6
B 50,000 5 10,000 6
C 20,000 5-15 4000-6000 48
D 1500-4000
E 15,000 1-10 6000 12-18
F 13,000-18,000 10 4500 30
500-1000 42
G 2000-10,000 25 2000 30
400 48
H 14,000-18,000 5-30 1200 30
I 2000 <1
a From responses to March 31, 1975, section 114 request (4).
October 1976 109Table 4. Reported cases of angiosarcoma of the liver among nonpolymerization workers
exposed to vinyl chloride.
Time from Tot
1st VC Diagnosis of Age lst expo- expo-
Case Birth or PVC angio- at sure to diag- sure, Date of
Country no. date exposurea sarcoma a diagnosis nosis, yr yr deatha
Fed. Rep. Germany 03 07-16-30 09-09-52b 03-00--73c 43 21 14 10-10-73
Fed. Rep. Germany 07 05-09-36 00-00-60d 00-00-74" 38 14 03 12-16-74
Great Britain 02 09-08-14 00-00-46e 02-00-70c 55 24 11 12-00-70
Italy 01 06-15-34 00-00-65f 04-19-71X 36 6 3 04-16-71
Sweden 02 11-27-11 00-00-45h 05-15-72c 61 27 23 08-16-72
United States 14 00-00-13 01-18-38i 06-00-73J 60 36 00 07-03-73
United States 15 00-00-25 00-000ook 07-00-72c 47 00 00 02-15-73
a "00" indicates unknown data.
b Loading pesticide cans with VC propellant.
c Microscopically confirmed angiosarcoma of the liver.
d Assistant factory chemist.
e Pouring PVC oil mixture onto fabric bases.
' Production of PVC sacks.
9 Angiosarcoma involving liver, lung, and pericardium.
pericardium.
h Production of vinyl chloride.
i Machine operator covering electrical wire with PVC
Although difficult to determine, primary site seems to be
plastic insulation.
i Diagnosis: sarcoma (possibly "angiosarcoma"), liver. Possibility of generalized neoplasm of the reticuloendo-
thelial cell system cannot be ruled out.
k Accountant at plant making PVC fabric.
exceeded the 1 ppm 8-hr time-weighted average
currently permitted by OSHA.
How low must you go before RVCM ceases
to represent a hazard? A "no-effect" level for
VCM carcinogenesis has not been found to
date; cancer has been found in all groups of
animals tested with nonzero concentrations of
inhaled VCM. Just how low are the VCM con-
centrations in fabrication plants now? Publi-
cation of monitoring data would be useful for
analysis of possible risks of harm to health.
A fabricated PVC product category with
wide consumer exposure is PVC automobile
upholstery, rooftops, and interior fittings. The
Table 5. Summary of VCM concentrations in PVC fabrication facilities.
Fraction >1
Type of plant Maximum Minimum Mean ppm
Firm and mold (7 plants)
NIOSH data
Breathing zone samples 12 <0.3 3 2/5
Area samples 8 <0.3 1.2 1/11
Source samples 340 <0.3 18 10/21
Pipe and mold (2 plants)
Industry data
Breathing zone samples <10 <0.1 <1 4/21
Area samples 35 <0.1 6 16/20
Source samples 540 <0.1 142 10/17
Environmental Health Perspectives 110EPA has a contract study, entitled, "Sampling
of Automobile Interiors for Vinyl Chloride
Monomer" (9) in progress. According to Hed-
ley, who is working on the EPA contract study
(personal communication, February 23, 1976),
of 7 cars in which 30-60 min grab samples
were taken in 1975 under varying heat and
sunlight conditions, one reading was 1.2 ppm
VCM, one 0.4 ppm and the remaining five
less than 0.05 ppm (the detection limit). The
car with the highest reading was sampled one
month after assembly under the following tem-
perature conditions: ambient 36°C, interior air
of car 600C, seat surface 66°C. No attempt was
made to follow any decrease in off-gassing of
RVCM over time.
Given the number of individuals exposed to
"new car atmospheres" and cars or other motor
vehicles generally, some further data on the
RVCM content of PVC auto fittings might be
useful.
Even if risk to consumers from RVCM in
PVC seat covers is low, what is the risk of
harm to persons working in automobile fac-
tories?
A recent study by Infante et al (10) is espe-
cially interesting. The data collected by In-
fante have been interpreted to suggest that
VCM may exert a mutagenic effect on sperm
cells of PVC production workers, leading to
an increase in fetal deaths among pregnancies
of workers' wives. Infante's findings are not
surprising in light of the demonstration by
Ducatman et al. (11) of chromosome aberra-
tions in PVC production workers and the find-
ing by Ames (12) that VCM is mutagenic in
a Salmonella test system.
The sewing of vinyl automobile upholstery
and other vinyl fabric automobile fittings is,
evidently, in large part woman's work. Even
given the multicomponent nature of the PVC
in auto fittings, it might be interesting to de-
termine the incidence of cancer, stillbirths, and
birth defects in offspring among women vinyl
auto upholstery workers.
What happens to PVC on pyrolysis? There
seems to be some disagreement as to whether
VCM is liberated (13) or whether the princi-
pal health threat from burning PVC is caused
by evolution of HCI (14,15). Has there been a
definitive demonstration that VCM is not
evolved during pyrolysis of PVC? What about
depolymerization on aging? in sunlight? in
heat?
PVC exposure has been linked both to der-
matitis and Raynaud's syndrome or occupa-
tional acroosteolysis (16). Dermatitis could be
attributable to several of the additives in PVC,
or possibly to VCM itself. A catalog of resin
components which have caused skin sensitiza-
tion reactions would be useful.
One of the important consumer uses of PVC
is in food packaging. Regulations recently pro-
posed by the United States Food and Drug Ad-
ministration (FDA) (17) deal with PVC food
packaging. Although industry data (18) have
been presented to FDA which indicate migra-
tion of VCM from PVC as below 50 ppb (the
"lowest detectable" level established by the
FDA proposal), challenges (19) have been
raised to permitting use of PVC food wrap if
there is any RVCM capable of migrating.
The debate about PVC food wrap points up
what may be the salient characteristic of PVC
considered as a source of residual VCM: RVCM
contained in PVC has now joined the ranks of
other carcinogenic substances whose presence
in trace amounts-the amounts limited only by
the means of detection-in the US food supply
is forbidden by the Delaney Clause, an amend-
ment to the United States Food, Drug and Cos-
metic Act. That clause reads in pertinent part:
". . . no additive shall be deemed to be safe
if it is found to induce cancer when ingested
by man or animal, or if it is found, after tests
which are appropriate for the evaluation of the
safety of food additives, to induce cancer in
man or animal . . ." (20).
FDA's attempt to set a nonzero tolerance for
VCM in food wrap has been challenged as illegal
due to conflict with the Delaney Clause (19).
It may be that final promulgation of a proposal
setting a nonzero tolerance for RVCM in food
wrap will be challenged in the courts.
Efforts to reduce VCM residual in PVC have
come a long way in just over two years. The
industry has demonstrated its ability to reduce
VCM levels in PVC production plants from
hundreds or thousands of ppm to a level close
to or at the OSHA 8-hr TWA of 1 ppm.
Since chemical reactions rarely go to comple-
tion and are usually reversible, will it ever be
possible to produce a PVC resin completely free
of residual VCM and incapable of breaking
down to release VCM? The stumbling block for
the continued health and growth of the PVC
industry may well prove to be not the threat of
massive doses of VCM and high potential risk
October 1976of cancer for the few, but the threat of low
doses of VCM and a low but nonzero risk of
cancer for the many.
The preSence of RVCM in PVC represents a
potential health hazard for the large number
of humans exposed to resin or, more commonly,
finished plastic goods. The dusty nature of PVC
resin may represent a health hazard for per-
sons with an occupational exposure to PVC.
Where could PVC dust represent a signifi-
cant hazard? In a polymerization plant, work
stations which could be dusty include drying
and bagging areas, storage rooms or silos
where PVC resin is held for shipment, mixing
areas in compounding and/or fabrication facil-
ities, and baghouses or cyclones in production
or fabrication facilities. If the dusty operations
are not completely isolated from the remainder
of the production or fabrication facility, dust
hazards could be present throughout the plant.
How dusty do PVC plants get? Two photo-
graphs (Figs. 1 and 2) taken in 1975 in a large
PVC polymerization facility in the U.S. (21)
may be of interest. Figure 1 gives a general
idea of the powdery coating on the equipment
in the bagging area; Figure 2 is a picture of the
floor of the plant: note the depth of the dust, as
indicated by the footprints.
PVC dust concentration data are not readily
available; at least, the author had difficulty ob-
taining such data from labor, government, aca-
demic, and industry sources. It would be very
helpful to those interested in problems of dust-
caused disease for industry, labor or govern-
ment to take measurements of PVC dust in the
workplace and make them public.
Particle sizes within the respirable range
have been noted (W. J. Nicholson, Mt. Sinai
School of Medicine, personal communication,
February 18, 1976) in a U.S. PVC polymeriza-
tion plant, not the same plant as the one in
which the photographs displayed as Figures 1
and 2 were taken.
.I
FIGURE 1. Bagging area in PVC manufacturing facility.
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lnmFIGURE 2. Floor of PVC manufacturing plant.
A number of clinical studies (22-24) have
demonstrated pulmonary abnormalities in PVC
production and fabrication workers. Abnormal-
ities have ranged from decreased pulmonary
function as measured by FEV to pulmonary
fibrosis. Given the data currently available,
work is needed to separate the effects on the
lung and respiratory system of VCM from
those of PVC dust.
Experimental studies associate pulmonary
fibrosis with exposure of animals to PVC dust.
In a recent paper from Italy, Frongia et al.
(25) performed a series of studies with a sim-
ple basic plan-place guinea pigs or rats in cages
in the bagging area of a PVC polymerization
plant and observe the effects on the animals'
lungs. These animal experiments were inspired
by a clinical report of PVC-induced pneumo-
coniosis (26). The Frongia group, after micro-
scopic examination of tissues of the animals
under study, concluded that they had demon-
strated a pneumoconiotic reaction brought on
by PVC dust. Experiments reported as "in
progress" as of late 1974 were designed to de-
termine whether the pulmonary fibrosis was
reversible on cessation of exposure to PVC.
Data on reversibility of pulmonary and respira-
tory effects of PVC exposure should also be
obtained for human populations.
Work is needed to determine whether VCM
exposure heightens pulmonary response to PVC
dust or whether, conversely, PVC dust may
convey low levels of VCM or additives to the
lungs.* Possible enhancement of dust effects
by other chemicals in the work atmosphere
and/or the additives in the PVC resin should
also be investigated.
PVC dust could also be swallowed. Volk-
heimer (27) has found that PVC particles can
* According to Miller et al. (23) ". . . If exposure to
vinyl chloride and/or PVC is causally related to air
flow impairment, we do not know which substance is
more pathogenic. The fine dust of the polymer might
be more likely to concentrate in and damage the small
airways. This dust, and other small respirable particles,
perhaps from tobacco smoke, may also serve as carriers
for molecules of a monomer gas to settle in these air-
ways."
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111..?.. -VIbe "persorbed" from the intestine into the
lymph or blood systems. The effect of locally
high concentrations of PVC particles carrying
minute amounts of potentially leachable RVCM
or additives merits investigation, especially as
concerns contact with lung or liver tissue.
The possibility of PVC dust serving as a skin
irritant should be explored. PVC dust could
serve as an efficient means for bringing a sen-
sitizing compound into contact with the skin.
The suggestive nature of the clinical and ex-
perimental data available at this time supports
reduction of PVC dust levels in polymerization,
comnounding and fabrication facilities. The
OSHA standard (28) does not include PVC
dust protection or reduction regulations, al-
though such regulations were recommended by
NIOSH.t
Major categories of PVC additives are color-
ants, fibrous reinforcements (e.g., asbestos),
flame retardants, plasticizers (e.g., phthalic
acid esters) and stabilizers (e.g., organotin
compounds) (28). Based on experimental and/
or clinical data, questions are in order as to the
safety of representatives of each of these chem-
ical classes.
For instance, Ames (29) has recently re-
ported that a certain flame retardant compound
used in children's sleepwear is highly mutage-
nic in a Salmonella test system. Compounds ex-
hibiting mutagenic activity in this bacterial
test system are likely to be carcinogens as well.
What about the toxicity of flame retardants
used in PVC plastics?
In September 1972, NIEHS held a confer-
ence on phthalic acid esters (30). What is the
t To date, neither the US OSHA nor the US EPA
has taken any specific steps to reduce PVC dust con-
sidered as dust. Dust reduction and protection was
recommended to the OSHA by NIOSH; EPA in its
standard support document (4), states:
"With regard to the potential problem of polyvinyl
chloride particulate as a possible cause of pneuumo-
coniosis, NIOSH is currently involved in experimental
studies on the effects of the particulate in animals. The
extent of public exposure (as opposed to occupational
exposure) to ambient concentrations of the particulate
is unknown at this time. Ambient measurements of
polyvinyl chloride particulate have not been made by
EPA in the vicinity of industrial sources because no
techniology is currently available for separating poly-
vinyl chloride particulate from total suspended par-
ticulate. As data become available from NIOSH and
other sources on the health effects of polyvinyl chloride
particulate, EPA may find that it is necessary to re-
evaluate the need to propose standards for polyvinyl
chloride particulate."
current thinking of regulators and researchers
regarding the safety of these chemicals?
There is considerable documentation of toxic
effects of certain organotin compounds (31).
The biocidal activity of organotin compounds,
several of which are being used as pesticides
at present, should cause concern about possible
effects of organotin plastics additives on human
health.
The possibility of complex interactions
among PVC plastics components and between
the components and living systems should be
emphasized. Most probably, very little is known
about these interactions.
NIEHS has in progress projects designed to
identify chemicals which should be studied for
possible adverse health effects for humans. Be-
cause of its wide population exposure due to
enormous production volume and broad spec-
trum of uses and health problems already asso-
ciated with VCM and PVC dust and certain ad-
ditives, PVC seems a likely candidate for fur-
ther investigation.
Given the current state of scientific knowl-
edge-at least as regards data available for
public scrutiny-producers and fabricators of
PVC cannot assure the public that PVC plastics
are safe for human use.
Therefore, interested scientists the world
over, whether working for industry, govern-
ment, or labor unions, or engaged in research
at universities, should make a concerted effort
to collect and analyze such data as are available
at present on possible risks of harm to human
health attributable to PVC. Scientists should
identify research which should be carried out to
determine whether or not the family of PVC
plastics is safe for general use, and seek the
necessary funding to carry out whatever stud-
ies are needed.
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